Clinical Trial Update: Study Evaluating the Efficacy and Safety of Etanercept in Chinese Subjects With Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy and safety of etanercept in Chinese subjects with rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: COMPLETED